Candida albicans is a commensal and a common constituent of the human microbiota; however, it can become pathogenic and cause infections in both immunocompetent and immunocompromised people. C. albicans exhibits remarkable metabolic versatility as it can colonize multiple body sites as a commensal or pathogen. Understanding how C. albicans adapts metabolically to each ecological niche is essential for developing novel therapeutic approaches. Purine metabolism has been targeted pharmaceutically in several diseases; however, the regulation of this pathway has not been fully elucidated in C. albicans. Here, we report how C. albicans controls the AMP de novo biosynthesis pathway in response to purine availability. We show that the lack of the transcription factors Grf10 and Bas1 leads to purine metabolic dysfunction, and this dysfunction affects the ability of C. albicans to establish infections.
KEYWORDS: Bas1, Candida albicans, Grf10, fungal pathogen, one-carbon metabolism, purine metabolism, transcriptional regulation, virulence
ABSTRACT
Candida albicans is an opportunistic human fungal pathogen that causes superficial fungal infections and lethal systemic infections. To colonize and establish infections, C. albicans coordinates the expression of virulence and metabolic genes. Previous work showed that the homeodomain transcription factor Grf10 is required for formation of hyphae, a virulence factor. Here we report global gene expression analysis of a grf10Δ strain using a DNA microarray and identify genes for de novo adenylate biosynthesis (ADE genes), one-carbon metabolism, and a nucleoside permease (NUP). Upregulation of these genes in response to adenine limitation required both Grf10 and the myb protein Bas1, as shown by quantitative real-time PCR (qRT-PCR). Phenotypic analysis showed that both mutants exhibited growth defects when grown in the absence of adenine, and the doubling time was slower for the bas1Δ mutant. Bas1 is required for basal expression of these genes, whereas NUP expression is more dependent upon Grf10. Disruption of BAS1 led to only modest defects in hypha formation and weak attenuation of virulence in a systemic mouse model of infection, as opposed to the previously reported strong effects found in the grf10Δ mutant. Our data are consistent with a model in which Grf10 coordinates metabolic effects on nucleotide metabolism by interaction with Bas1 and indicate that AMP biosynthesis and its regulation are important for C. albicans growth and virulence.
IMPORTANCE Candida albicans is a commensal and a common constituent of the human microbiota; however, it can become pathogenic and cause infections in both immunocompetent and immunocompromised people. C. albicans exhibits remarkable metabolic versatility as it can colonize multiple body sites as a commensal or pathogen. Understanding how C. albicans adapts metabolically to each ecological niche is essential for developing novel therapeutic approaches. Purine metabolism has been targeted pharmaceutically in several diseases; however, the regulation of this pathway has not been fully elucidated in C. albicans. Here, we report how C. albicans controls the AMP de novo biosynthesis pathway in response to purine availability. We show that the lack of the transcription factors Grf10 and Bas1 leads to purine metabolic dysfunction, and this dysfunction affects the ability of C. albicans to establish infections.
INTRODUCTION
Candida albicans is part of the human microbiota that resides harmlessly in the body; the immune system and other microbial communities play important roles by protecting the host from C. albicans overgrowth and tissue invasion (1, 2). However, C. albicans is an opportunistic pathogen and can become virulent in people with compromised immune systems. C. albicans causes a range of conditions from superficial infections in the epithelial mucosa to life-threatening bloodstream infections. To survive and cause infections in these diverse niches, C. albicans displays remarkable morphology reprogramming and metabolic adaptation. Morphological switching between yeast and filamentous forms is strongly associated with virulence (3–6). Transcriptomic analyses of strains with mutations in transcription factors (TFs) such as Gcn4, Tup1, Efg1, and Ace2 have revealed unexpected links between metabolism and virulence in C. albicans (7–11). These studies demonstrate that TFs coordinate the expression of genes related to both metabolism and virulence to ensure appropriate expression in particular microenvironments (12). However, it is still unclear if there are other TFs that regulate target genes in a similar manner and how TFs mechanically link metabolism and morphogenesis.
We recently reported on a role for the Grf10 homeodomain TF in regulating C. albicans morphogenesis (13). The grf10Δ mutant shows dramatically decreased hyphal growth on solid medium and a delay in germ tube formation in liquid medium. In addition, processes related to filamentation are strongly affected in the grf10Δ mutant, including an inability to generate chlamydospores, decreased biofilm formation, and attenuated virulence in mouse models of systemic infection (13, 14). Overexpression of GRF10 triggers filamentation under conditions that normally promote yeast growth (15). Consistent with a role for Grf10 in morphogenesis, expression of GRF10 is highly induced during filamentation (13), and GRF10 is one of eight core target genes upregulated by the biofilm master regulators (16). Together, these results show that Grf10 is a critical TF that regulates filamentation and morphology-related traits in C. albicans.
The ortholog of GRF10 from Saccharomyces cerevisiae, PHO2 (ScPHO2), plays an important role in regulating metabolism. ScPho2 upregulates genes for purine biosynthesis, one-carbon metabolism, and histidine biosynthesis with the coregulator ScBas1, and it upregulates genes for acquisition and storage of inorganic phosphate with the coregulator ScPho4 (17–19). In C. albicans, grf10Δ (referred to as pho2Δ) and bas1Δ mutants exhibit a leaky adenine auxotrophy, whereas pho4Δ but not grf10Δ mutants exhibit a growth defect under phosphate limitation conditions (20), indicating a divergence of function. Importantly, purine biosynthetic genes have been shown to be involved with virulence in C. albicans (21–23), underlying a critical role of this metabolic pathway in fungal pathogenicity. Although maintenance of purine nucleotide pools is crucial for cell survival and pathogenicity, the genetic regulation of this pathway has not been well characterized in C. albicans.
Given the role for Grf10 in filamentation and virulence (13) and the observation that transcription factors coordinate regulation of virulence and metabolic genes (12), we investigated transcriptional regulation by Grf10. DNA microarray analysis was used to identify genes whose expression was dependent upon Grf10; genes for adenylate biosynthesis and also in diverse pathways such as iron homeostasis, one-carbon metabolism, adhesion, and other metabolic pathways were uncovered. The bas1Δ mutant had a lower growth rate than the grf10Δ strain in medium lacking adenine (−Ade). Using quantitative real-time PCR (qRT-PCR), the gene expression patterns of the wild type (WT), grf10Δ, and bas1Δ strains were determined in response to adenine limitation. Consistent with the DNA microarray data and growth phenotype, the bas1Δ and grf10Δ strains failed to derepress the ADE regulon and one-carbon metabolic genes, and the bas1Δ mutant showed a stronger ADE gene regulation defect than the grf10Δ mutant. BAS1 plays an important role in pathogenicity, as the mutant exhibited attenuated virulence, although weaker than that of the grf10Δ mutant (13).
RESULTS
Identification of potential Grf10 target genes.
To characterize the global Grf10 target genes under yeast growth conditions, we performed DNA microarray analysis and determined differential gene expression in the grf10Δ (RAC117) mutant versus a GRF10 strain (DAY185). Strains were grown at 30°C to the mid-log phase in synthetic dextrose (SD) medium with minimal supplements. The potential Grf10 targets were defined as those genes, out of 7,860 potential loci, in which expression was altered 2-fold or greater with a P value of 1 × 10−5 or lower. Our results revealed 25 genes that showed lower expression levels and 36 genes that showed higher expression levels in the grf10Δ mutant (Table 1; see Table S1 in the supplemental material). The genes that were differentially expressed in the grf10Δ mutant were sorted by the web-based GO Term Finder tool available on the Candida Genome Database (24) and manually sorted for uncharacterized genes.
TABLE 1 .
Group/GO term | FungiDB ID no. | Gene name | Function | Fold change | P value |
---|---|---|---|---|---|
Downregulated genes | |||||
Purine metabolism (GO ID no. 6189, 46040, 6188, 72522, 9127) | orf19.3870 | ADE13 | Adenylosuccinate lyase | −4.14 | 4.48E−7 |
orf19.7484 | ADE1 | Phosphoribosylaminoimadazole succinocarboxamide synthetase | −3.06 | 4.66E−8 | |
orf19.492 | ADE17 | 5-Aminoimidazole-4-carboxamide ribotide transformylase | −2.85 | 8.01E−7 | |
orf19.5061 | ADE5,7 | Phosphoribosylamine-glycine ligase and phosphoribosylformylglycinamidine cyclo-ligase | −2.50 | 1.91E−6 | |
orf19.5906 | ADE2 | Phosphoribosylaminoimadazole carboxylase | −2.28 | 6.97E−6 | |
orf19.6317 | ADE6 | 5-Phosphoribosylformyl glycinamidine synthetase | −1.97 | 9.74E−6 | |
One-carbon metabolism | orf19.5750 | SHM2 | Cytoplasmic serine hydroxymethyltransferase | −3.48 | 1.50E−8 |
orf19.5838 | SER2 | Ortholog(s) has phosphoserine phosphatase activity | −2.48 | 4.58E−6 | |
orf19.3810 | MTD1 | Ortholog(s) has methylenetetrahydrofolate dehydrogenase (NAD+) activity | −3.52 | 1.36E−6 | |
orf19.1117 | Protein similar to Candida boidinii formate dehydrogenase | −3.69 | 5.00E−8 | ||
orf19.1774 | Predicted formate dehydrogenase | −4.51 | 8.99E−8 | ||
Iron metabolism | orf19.1932 | CFL4 | C terminus similar to ferric reductases | −3.89 | 1.12E−8 |
orf19.1930 | CFL5 | Ferric reductase | −3.02 | 1.09E−6 | |
Transcription | orf19.5338 | GAL4 | Zn(II)2 Cys6 transcription factor; involved in control of glycolysis | −2.03 | 4.66E−6 |
Miscellaneous | orf19.4025 | PRE1 | Putative β4 subunit of 20S proteasome | −40.42 | 1.23E−10 |
orf19.4028 | RER2 | cis-Prenyltransferase involved in dolichol synthesis | −12.76 | 1.47E−8 | |
orf19.6570 | NUP | Nucleoside permease; transports adenosine and guanosine | −7.15 | 1.65E−8 | |
orf19.1788 | XKS1 | Putative xylulokinase | −5.29 | 8.37E−9 | |
orf19.4024 | RIB5 | Putative riboflavin (vitamin B2) synthase | −4.48 | 7.32E−8 | |
orf19.4394 | Protein of unknown function | −4.24 | 3.89E−8 | ||
orf19.4814 | Uncharacterized | −2.96 | 2.15E−7 | ||
orf19.3222 | Predicted vacuolar protein | −2.62 | 4.46E−7 | ||
orf19.300 | AIP2 | Putative actin-interacting protein; S. cerevisiae ortholog is d-lactate dehydrogenase | −2.41 | 8.58E−8 | |
orf19.4441 | Ortholog(s) involved in initiation of DNA replication | −2.16 | 2.97E−7 | ||
orf19.1344 | Protein of unknown function | −2.10 | 2.54E−6 | ||
Upregulated genes | |||||
Cell adhesion and biofilm formation (GO ID no. 7155, 22610, 42710, 44011, 51703) | orf19.3548.1 | WH11 | White-phase yeast transcript | 10.64 | 1.07E−8 |
orf19.3160 | HSP12 | Heat shock protein | 3.85 | 1.48E−7 | |
orf19.4216 | Putative heat shock protein | 3.64 | 1.88E−7 | ||
orf19.2121 | ALS2 | ALS family protein; role in adhesion and biofilm formation | 3.64 | 1.70E−6 | |
orf19.4555 | ALS4 | Glycosylphosphatidylinositol-anchored adhesin; roles in adhesion and germ tube induction | 3.47 | 2.37E−7 | |
orf19.5437 | RHR2 | Glycerol 3-phosphatase; roles in osmotic tolerance | 3.11 | 3.16E−6 | |
orf19.508 | QDR1 | Putative antibiotic resistance transporter | 2.19 | 1.34E−5 | |
orf19.4477 | CSH1 | Aldo-keto reductase; role in fibronectin adhesion and cell surface hydrophobicity | 2.11 | 2.51E−5 | |
orf19.1258 | Adhesin-like protein | 2.35 | 2.15E−6 | ||
orf19.2475 | PGA26 | GPI-anchored adhesin-like protein of cell wall; role in cell wall integrity | 2.00 | 2.36E−6 | |
Miscellaneous | orf19.1868 | RNR22 | Putative ribonucleoside-diphosphate reductase | 4.27 | 1.10E−7 |
orf19.2531 | CSP37 | Cell wall protein, stationary-phase enriched, GlcNAc-induced | 3.58 | 9.37E−8 | |
orf19.2633.1 | Uncharacterized | 3.23 | 9.14E−8 | ||
orf19.1847 | ARO10 | Aromatic decarboxylase; catabolic alcohol synthesis | 3.04 | 1.65E−7 | |
orf19.2048 | Protein of unknown function | 3.00 | 1.25E−6 | ||
orf19.1863 | Predicted Rho guanyl-nucleotide exchange factor activity | 2.69 | 1.34E−5 | ||
orf19.842 | ASR3 | Adenylyl cyclase and stress-responsive protein | 2.50 | 4.13E−8 | |
orf19.3803 | MNN22 | α-1,2-Mannosyltransferase | 2.50 | 2.30E−7 | |
orf19.125 | EBP1 | NADPH oxidoreductase | 2.49 | 1.30E−6 | |
orf19.1862 | Possible stress protein | 2.36 | 1.51E−5 | ||
orf19.251 | GLX3 | Glutathione-independent glyoxalase | 2.36 | 2.52E−6 | |
orf19.3061.1 | Ortholog of S. cerevisiae proteins Rps22A and Rps22B | 2.32 | 1.22E−5 | ||
orf19.5620 | Protein of unknown function | 2.24 | 1.38E−6 | ||
orf19.1473 | 2-Hydroxyacid dehydrogenase domain-containing protein | 2.20 | 2.85E−5 | ||
orf19.1149 | MRF1 | Putative mitochondrial respiratory protein | 2.19 | 2.69E−6 | |
orf19.4003 | TIP20 | Possibly involved in retrograde transport between Golgi apparatus and endoplasmic reticulum | 2.01 | 3.78E−6 | |
orf19.1152 | Protein of unknown function; induced in core stress response | 2.01 | 1.06E−5 | ||
orf19.6816 | Putative xylose and arabinose reductase | 2.00 | 5.98E−7 | ||
orf19.2769 | Putative protease B inhibitor | 2.00 | 3.17E−6 | ||
orf19.2047 | Putative protein of unknown function; Hap43p-repressed gene | 2.00 | 1.04E−5 | ||
orf19.1691 | S. cerevisiae ortholog is cytochrome c oxidase subunit | 2.00 | 1.54E−5 |
Among the differentially expressed genes in the grf10Δ mutant, we found that most of the genes necessary for de novo adenylate synthesis—ADE2, ADE5,7, ADE6, ADE13, and ADE17—were strongly downregulated (Fig. 1; see Table S2 in the supplemental material). Additionally, we detected a decrease in expression of genes involved with the one-carbon metabolic pathway, which supplies the substrates glycine and N10-formyl tetrahydrofolate into the purine biosynthetic pathway (25). This gene set included MTD1, SHM2, SER2, and putative formate dehydrogenase-encoding genes orf19.1774 and orf19.1117. Additionally, we found lower expression of a gene encoding a nucleoside permease (NUP [orf19.6570]) potentially capable of transporting adenosine and guanosine (26). These gene products are all involved in the de novo biosynthesis, uptake, and interconversion pathways for purine nucleotides and account for 11 of the 25 downregulated genes. These results suggest that Grf10 is likely to directly regulate genes in purine de novo biosynthesis and related pathways.
Other downregulated genes in the grf10Δ strain were in diverse pathways. The uncharacterized gene PRE1, which encodes the putative β4 subunit of the 20S proteasome, showed the greatest decrease in gene expression (~40-fold change) (Table 1; Table S2); ubiquitination and protein degradation have been implicated in metabolic adaptation and virulence (27). Gene RER2 was downregulated 13-fold; RER2 encodes cis-prenyltransferase, responsible for protein glycosylation, cell wall integrity, and cell separation (28). The CFL4 and CFL5 genes exhibit ~3- to 4-fold lower expression; these genes encode putative ferric reductases that may play a crucial role in iron homeostasis and virulence in C. albicans (29, 30). RIB5, which encodes a putative riboflavin synthase, is downregulated ~4.5-fold in the mutant, and GAL4, which encodes a transcription factor that regulates glycolysis (31, 32), was expressed ~2-fold lower.
The majority of the upregulated genes are involved in the cellular stress response, cell adhesion, and metabolic pathways (see Table S3 in the supplemental material). WH11 shows the greatest increase in gene expression (~10-fold) in the grf10Δ mutant. WH11 encodes a protein of unknown function but is homologous to HSP12 of S. cerevisiae; it is expressed specifically in white-phase yeast cells, and its transcript is absent in hyphal cells (33). Several genes that had been identified as the core stress response genes, including RHR2, HSP12, and GLX3, are highly upregulated in the in the grf10Δ mutant (34, 35). Two members of the ALS gene family, ALS2 and ALS4, which function in cell adhesion and biofilm formation (36), are upregulated ~3.5-fold, and MNN22, which encodes an α-1,2-mannosyltransferase that participates in cell wall biosynthesis (37), was expressed 2.5-fold higher. The RNR22 gene, which encodes a putative ribonucleoside-diphosphate reductase, was expressed ~4-fold higher in the grf10Δ mutant. Finally, Gene Ontology (GO) term analysis with the GO Term Finder identified genes associated with carbohydrate metabolism, including d-xylose, arabinose, and pentose catabolic processes (Table S3) (P < 0.05). To summarize, the upregulated genes are involved in a range of biological processes.
The grf10Δ and bas1Δ mutants exhibit a growth defect in response to adenine limitation.
In S. cerevisiae, ScPho2 interacts with ScBas1 to regulate adenylate and one-carbon metabolic genes (reviewed in reference 19). We examined the regulation of these genes under adenine limitation by Grf10 and its predicted protein partner Bas1 in C. albicans. We disrupted BAS1 and GRF10 genes in C. albicans strain BWP17 and also assayed the bas1Δ (TF016) and grf10Δ (TF021) mutants from the SN152 background (20) since strain background can influence phenotype. The slow growth of the null mutant strains on solid synthetic complete (SC) medium lacking adenine (SC−Ade) was more evident at 16 h than at 48 h, was more pronounced in the bas1Δ mutants than in the grf10Δ mutants, and was stronger in the SN152 background than in the BWP17 background (Fig. 2). By 48 h, only the bas1Δ strain exhibited slower growth than the parental wild-type strain; the bas1 heterozygotes and all of the grf10 mutants (heterozygotes and null) in both strain backgrounds were indistinguishable from their isogenic wild-type strains (Fig. 2). The adenine auxotrophy shown in Fig. 2 was strongest when cells received more nutrients, with growth in SC medium, than when we used SD medium (data not shown). We found that the adenine auxotrophic phenotype in C. albicans was weaker than that detected in the mutants from S. cerevisiae (data not shown).
In S. cerevisiae, ScPho2 interacts with ScPho4 to activate expression of genes encoding secreted acid phosphatases and phosphate transporters (19). To determine if Grf10 is important for the upregulation of PHO genes, the ability of the Candida grf10Δ mutant to grow on YPD medium containing 0.2 mM adenine and lacking inorganic phosphate was assessed. The grf10Δ mutant was able to grow without inorganic phosphate supplementation in the SN152 strain background (Fig. 3), as well as in the BWP17 background (data not shown). These findings contrast with the inability of both the C. albicans pho4Δ and S. cerevisiae pho2Δ mutants to grow, indicating that Grf10 is not required under phosphate starvation in C. albicans.
We tested a broad range of conditions to look for additional phenotypes, comparing the bas1Δ (RAC108) and grf10Δ (RAC117) strains with BWP17. Neither of the null mutations led to sensitivity to temperature (37, 40, and 45°C), cations (NaCl, KCl, and LiCl2), pH (range from pH 4.0 to 9.0), or oxidative stress (hydrogen peroxide, t-butyl hydroperoxide, and menadione).
To quantify adenine auxotrophy, we measured growth rates in liquid SC medium containing (+Ade) and lacking (−Ade) adenine. In the absence of adenine, we found that the bas1Δ mutants took nearly twice as long to grow as their respective WT strains (Table 2). In the grf10Δ mutants, there was only an ~10% increase in doubling times in both stain backgrounds. Restoring an allele of BAS1 or GRF10 to the null mutants complemented the growth defect—partially for BAS1 and fully for GRF10 (Table 2). In the presence of adenine, all of the mutants grew at the same rate as the wild type. Overall, the bas1Δ mutants showed stronger growth defects than the grf10Δ mutants in response to the absence of adenine. These results quantify the extent of the slow growth and demonstrate that the transcription factors differentially affect the Ade− phenotype.
TABLE 2 .
Strain | Doubling time (min) |
Ratio | |
---|---|---|---|
+Ade | −Ade | ||
DAY286 (WT) | 107 ± 1 | 104 ± 4 | 0.97 |
BAS1/bas1Δ mutant | 106 ± 1 | 103 ± 1 | 0.97 |
bas1Δ mutant | 107 ± 1 | 202 ± 6 | 1.89 |
BAS1 restored | 109 ± 4 | 140 ± 2 | 1.28 |
GRF10/grf10Δ mutant | 108 ± 1 | 103 ± 1 | 0.95 |
grf10Δ mutant | 104 ± 2 | 118 ± 1 | 1.13 |
GRF10 restored | 104 ± 2 | 103 ± 4 | 0.99 |
OHWT (WT) | 107 ± 2 | 106 ± 1 | 0.99 |
bas1Δ mutant | 110 ± 2 | 217 ± 5 | 1.97 |
BAS1 restored | 106 ± 2 | 143 ± 1 | 1.35 |
grf10Δ mutant | 107 ± 4 | 118 ± 2 | 1.10 |
GRF10 restored | 107 ± 2 | 106 ± 3 | 0.99 |
Bas1 and Grf10 upregulate the adenylate and one-carbon metabolic genes.
To examine transcription promoted by Grf10 and Bas1, we performed qRT-PCR to detect the expression of the nine ADE genes that constitute the adenylate biosynthetic pathway (Fig. 1). The wild-type, bas1Δ, and grf10Δ strains were grown at 30°C in SC medium with adenine and then shifted to medium lacking adenine, and cells were collected after 15 min for RNA preparation. ADE gene expression was compared with TEF1 using the threshold cycle (ΔCT) method, and normalized to the expression in the wild-type strain under repressing (+Ade) conditions.
ADE genes were derepressed by 2- to 9-fold in the WT strain under adenine-limiting conditions (Fig. 4). Deletion of either Bas1 or Grf10 led to decreased expression of every ADE gene under adenine-limiting conditions, indicating that both Bas1 and Grf10 are required to achieve full expression. Bas1 appears to play an important role in maintaining basal expression, because the expression of several of the genes (ADE4, ADE6, and ADE13) was reduced by 2-fold or more in the bas1Δ strain relative to the WT under repressing (+Ade) conditions; however, basal expression of the ADE genes was not affected in the grf10Δ mutant. We examined the expression of ADE13 in the heterozygous strains to determine if there was a dosage effect. Expression of ADE13 in the bas1 (RAC105) and grf10 (RAC114) heterozygous mutants was not different from that in the wild-type strain DAY286 (see Fig. S1 in the supplemental material). Expression of ADE13 was partially or fully restored when BAS1 (RAC111) or GRF10 (RAC120), respectively, was restored to the genome, consistent with the growth phenotypes shown in Fig. 2 and Table 2.
Given the metabolic connection between adenylate and one-carbon metabolism and the results from the DNA microarray, we examined regulation patterns of one-carbon metabolic genes in C. albicans. We examined MTD1, SHM2, and ADE3 (MIS11) by qRT-PCR as described above. When the wild-type strain was grown in medium lacking adenine, we detected the substantial upregulation of the one-carbon metabolic genes by 3- to 33-fold compared to basal expression in the WT strain (Fig. 5). This result indicates that adenine limitation leads to the coregulation of one-carbon metabolic genes. Because the expression of SHM2 and ADE3 genes in the bas1Δ strain was significantly below the WT levels (≥2-fold change), Bas1 was required for the basal expression of one-carbon metabolic genes. We found that basal expression of MTD1, SHM2, and ADE3 (MIS11) genes is unaffected in the grf10Δ mutant.
Together, our results show that adenine limitation leads to cotranscriptional regulation of adenylate and one-carbon metabolic genes in C. albicans. Bas1 regulates both the basal and derepressed expression of ADE and one-carbon metabolic genes; however, Grf10 is necessary for the full upregulation of gene expression during derepression.
Bas1 and Grf10 regulate NUP under the adenine derepressing conditions.
Our microarray data showed that the NUP gene, which encodes a nucleoside permease (26), was one of the genes most affected by the loss of Grf10. We reasoned that adenine limitation and both transcription factors Grf10 and Bas1 might also lead to the upregulation of this gene. We examined NUP gene expression by qRT-PCR as described above. The NUP gene was derepressed 17-fold in the WT strain grown in –Ade medium (Fig. 5). Both Bas1 and Grf10 were required for this transcriptional derepression; however, in contrast to the ADE and one-carbon metabolic genes, the basal and high-level expression of the NUP gene were more dependent on Grf10 than on Bas1. In the grf10Δ strain, NUP gene expression at basal levels (+Ade) was significantly below the WT levels (~2-fold change) and there was no derepression to high levels. However, in the bas1Δ strain, basal expression of NUP was not affected, and there was modest (3.4-fold) upregulation under –Ade conditions.
Bas1 is implicated in virulence in an animal model of disseminated candidiasis.
Grf10 regulates morphogenesis and affects virulence (13, 15) in addition to regulating metabolic genes. This led us to examine the morphology and pathogenicity of the bas1Δ mutant. To investigate the role of Bas1 in morphology, we examined macroscopic colonies of the wild-type (BWP17), bas1Δ (RAC108), BAS1 heterozygote (RAC105), and BAS1 complemented (RAC111) strains under hypha-inducing conditions on solid M-199, Spider, and YPD medium containing 10% serum (Fig. 6), and compared these results with those reported for the grf10Δ mutants (13). On both solid M-199 and Spider media, mutations in bas1 led to a decrease in the length of the filamentous region at the periphery of the colony, and on serum-containing medium, the bas1Δ colonies showed discontinuous hypha production in the periphery (Fig. 6). Addition of adenine to Spider medium did not alter this phenotypic difference between the null mutant and the wild type (data not shown). We also tested synthetic low-ammonia dextrose (SLAD) and SD+GlcNAc media, supplemented with and without adenine, for morphological differences; however, both the bas1Δ and grf10Δ mutants responded in the same manner as BWP17 to these hypha-inducing conditions (data not shown). Overall, the bas1Δ mutant exhibited mild morphological defects that are not as severe as those found in the grf10Δ mutant (13).
To assess the involvement of Bas1 in fungal virulence, we used a mouse model of disseminated candidiasis (38), comparing the survival rates of mice infected with the wild-type and bas1 mutant strains. Mice infected with either of the two heterozygous BAS1 mutants (RAC105 and RAC111) or the wild-type strain (DAY185) succumbed in 7 to 8 days (Fig. 7). The mice infected with the bas1Δ mutant (RAC108) survived longer than these, but all mice succumbed by about 2 weeks postinfection. The bas1 null mutant was significantly different from the control strain (P = 7.53E−6), but neither the heterozygous mutant nor the restored strain was significantly different from the control (P > 0.05). We note that these strains differ in their auxotrophies for arginine and histidine; however, these differences are unlikely to have affected virulence because, first, the two heterozygotes RAC105 and RAC111 had similar virulence profiles in spite of their auxotrophic differences, and second, Noble and Johnson (39) found that neither the arg4Δ nor his1Δ mutation had an effect on virulence in the mouse systemic infection model. While ectopic URA3 expression can affect virulence (40), this did not occur in this experiment because DAY185, RAC108, and RAC111 have the same virulence (Fig. 7), even though they differ in the location of URA3 (at ARG4 or BAS1). This finding indicates that the bas1Δ strain is attenuated for virulence in C. albicans.
DISCUSSION
This study demonstrates that expression of nucleoside permease, adenylate biosynthetic, and one-carbon metabolic genes are transcriptionally regulated in C. albicans and that the Bas1 and Grf10 transcription factors are required for this regulation. The modulation of ADE gene expression by these transcription factors could potentially promote the survival of C. albicans in response to purine fluctuation in different sites on the human host. Bas1 plays a more critical role in the regulation of ADE and one-carbon metabolic genes than does Grf10. Indeed, the more severe gene expression defect in the bas1Δ mutant than in the grf10Δ mutant may explain its stronger growth defect (20) (Table 2; Fig. 4 and 5).
Our study indicates a largely but not wholly conserved role for the Bas1 and Grf10 orthologs of C. albicans. C. albicans Bas1 (CaBas1) shows conservation of gene targets with Bas1 from S. cerevisiae and Ashbya gossypii. One key difference is that CaBas1 regulates both basal and derepressed expression, whereas ScBas1 does not affect basal expression (19). The A. gossypii Bas1 (AgBas1) homolog controls genes for de novo purine biosynthesis as well as those in other metabolic pathways such as one-carbon metabolism and riboflavin biosynthesis (41). Another difference is that expression of ADE3 and NUP is under the control of these factors in C. albicans. The NUP nucleoside permease transports adenosine and guanosine (26). There is no orthologue of NUP in S. cerevisiae; however, parasitic fungi and protozoa such as Microsporidia, Leishmania, Trypanosoma, Trichomonas, and Plasmodium require nucleoside permeases as they lack de novo purine biosynthesis (42–45). Although C. albicans is capable of synthesizing purines de novo, it may be possible that it upregulates the NUP gene to scavenge purine nucleosides.
It is striking that the adenine auxotrophy due to loss of Bas1 and Grf10 is weaker in C. albicans than it is in S. cerevisiae. This difference may reflect the different ecological niches for these species. S. cerevisiae is a generalist adapted to fruit (e.g., grapes) and to fermentation under anaerobic conditions (46). It can survive in a wide range of environments with various levels of nutrients, temperatures, osmolarities, and pHs; because of this, S. cerevisiae must tightly regulate gene expression to survive and respond to these diverse conditions (46, 47). C. albicans is adapted to the human host, colonizing different sites such as skin, mucosal tissue, and the bloodstream. Purine bases and nucleosides in plasma and extracellular fluids are found in low, virtually constant levels of ~4 μM (48, 49); high basal gene expression and feedback inhibition of the biosynthetic pathway could be sufficient to maintain intracellular nucleotide pools. In the intestine, there is intense competition among the microbial communities for nutrients released upon digestion. Nucleotidase in the small intestine hydrolyzes nucleotides to nucleosides (50), which would be available for uptake by nucleoside permease. It is interesting to speculate that the NUP gene of Candida may be particularly important for adaptation to this niche. Other infection sites may be more limited for purines.
Several reports demonstrate the crucial role of nucleotide biosynthesis for pathogens during infections. In C. albicans, mutants defective in purine or pyrimidine biosynthesis are avirulent during infections (51). Nucleotide biosynthesis is critical for the growth of bacterial pathogens such as Escherichia coli, Salmonella enterica, Bacillus anthracis, and Staphylococcus aureus in human blood serum or abscesses (52, 53). These reports strongly support the idea that pathogens commonly require nucleotide biosynthesis for growth during infection. Transcriptional upregulation in these niches may be crucial for full pathogenesis of Candida, accounting for the virulence attenuation in the bas1Δ (Fig. 7) and grf10Δ mutants (13).
Morphological changes in C. albicans from yeast to hyphal forms have long been linked to virulence, while emerging evidence shows that metabolic ability is also strongly linked to virulence (12). Morphological changes and metabolic adaptation are each controlled by complex transcriptional networks and are coordinated by transcription factors (12). Bas1 plays a prominent role in metabolism but only a marginal role in morphogenesis. However, Grf10 coregulates both virulence attributes (morphogenesis [13]) and fitness attributes (metabolism [this work]). We hypothesize that Grf10 regulates adenylate metabolism, morphogenesis, and other processes by interacting with different transcription factors. Future studies will shed light on how Grf10 coordinates fitness and virulence attributes.
MATERIALS AND METHODS
Yeast strains.
The strains of C. albicans used and generated in this study are listed in Table 3. Strains RAC114, RAC117, and RAC120 were described previously (13). Strains DAY185 and DAY286 were obtained from A. Mitchell (54), and strains SN152, OHWT, TF004Δ, TF016Δ, and TF021Δ (20) were obtained from the Fungal Genetics Stock Center. BWP17 (55) served as the parent strain for construction of the BAS1 mutant strains (detailed below). Strains RAC255 and RAC256 carry restored alleles of BAS1 and GRF10, respectively, in strains TF016Δ and TF021Δ (detailed below).
TABLE 3 .
Strain | Relevant genotype | Reference or source |
---|---|---|
BWP17 | ura3Δ::λimm434/ura3Δ::λimm434 his1::hisG/his1::hisG arg4::hisG/arg4::hisG | 56 |
DAY185 | ura3Δ::λimm434/ura3Δ::λimm434 his1::hisG::HIS1/his1::hisG ARG4::URA3::arg4::hisG/arg4::hisG | 54 |
DAY286 | ura3Δ::λimm434/ura3Δ::λimm434 his1::hisG/his1::hisG ARG4::URA3::arg4::hisG/arg4::hisG | 54 |
RAC105 | ura3Δ::λimm434/ura3Δ::λimm434 arg4::hisG/arg4::hisG his1::hisG/his1::hisG BAS1/bas1Δ::URA3 | This study |
RAC108 | ura3Δ::λimm434/ura3Δ::λimm434 arg4::hisG/arg4::hisG his1::hisG/his1::hisG bas1Δ::ARG4/bas1Δ::URA3 | This study |
RAC111 | ura3Δ::λimm434/ura3Δ::λimm434 arg4::hisG/arg4::hisG his1::hisG/his1::hisG bas1Δ::ARG4/bas1Δ::URA3::<BAS1, HIS1> | This study |
RAC114 | ura3Δ::λimm434/ura3Δ::λimm434 arg4::hisG/arg4::hisG his1::hisG/his1::hisG GRF10/grf10Δ::URA3 | 13 |
RAC117 | ura3Δ::λimm434/ura3Δ::λimm434 arg4::hisG/arg4::hisG his1::hisG/his1::hisG grf10Δ::ARG4/grf10Δ::URA3 | 13 |
RAC120 | ura3Δ::λimm434/ura3Δ::λimm434 arg4::hisG/arg4::hisG his1::hisG/his1::hisG grf10Δ::ARG4/grf10Δ::URA3::<GRF10, HIS1> | 13 |
SN152 | arg4Δ/arg4Δ leu2Δ/leu2Δ his1Δ/his1Δ URA3/ura3Δ IRO1/iro1Δ | 39 |
OHWT | arg4Δ/arg4Δ::ARG4 leu2Δ/leu2Δ::LEU2 his1Δ/his1Δ::HIS1 URA3/ura3Δ IRO1/iro1Δ | 20 |
TF016 | arg4Δ/arg4Δ leu2Δ/leu2Δ his1Δ/his1Δ URA3/ura3Δ IRO1/iro1Δ bas1Δ::HIS1/bas1Δ::LEU2 | 20 |
RAC255 | arg4Δ/arg4Δ leu2Δ/leu2Δ his1Δ/his1Δ URA3/ura3Δ IRO1/iro1Δ bas1Δ::HIS1/bas1Δ::LEU2::<BAS1, SAT1 flipper> | This study |
TF021 | arg4Δ/arg4Δ leu2Δ/leu2Δ his1Δ/his1Δ URA3/ura3Δ IRO1/iro1Δ grf10Δ::HIS1/grf10Δ::LEU2 | 20 |
RAC256 | arg4Δ/arg4Δ leu2Δ/leu2Δ his1Δ/his1Δ URA3/ura3Δ IRO1/iro1Δ grf10Δ::HIS1/grf10Δ::LEU2::<GRF10, SAT1 flipper> | This study |
TF004 | arg4Δ/arg4Δ leu2Δ/leu2Δ his1Δ/his1Δ URA3/ura3Δ IRO1/iro1Δ pho4Δ::HIS1/pho4Δ::LEU2 | 20 |
PCR with pGEM-URA3 (56) and primers BAS1-5DR and BAS1-3DR (portion of the primer that anneals with the vector is shown in lowercase in Table 4) was used to generate a fragment carrying the bas1Δ::URA3 allele. After transformation of BWP17, the deletion was confirmed in strain RAC105 using primers to BAS1 and URA3. To generate the null mutant, the same primers and pRS-ARG4 were used to amplify a fragment carrying the bas1Δ::ARG4 allele. This fragment was transformed into RAC105, and confirmation of the genotype in strain RAC108 was made by PCR and by Southern analysis (data not shown).
TABLE 4 .
Name | Description | Sequence (5′→3′)a |
---|---|---|
BAS1-5DR | BAS1-pGEM3 sequence | CCAAATCCTCTGATGGTTTTATGCAACCCAGATTATTTTAGCATTCTAACTCGTATCAGCgttttcccagtcacgacgtt |
BAS1-3DR | BAS1-pGEM3 sequence | ACTACAATCAATCATCGTATATTCTTACATTAGCATCTGATTCTTATACACTAGAATACCtgtggaattgtgagcggata |
BAS1-DF | Diagnostic forward primer | GTGAAGTTTCTGATGCGAC |
BAS1-DR | Diagnostic reverse primer | GCCAAGGGACCTATTTGC |
B1RF | Restored allele forward primer | CTGGATCCATTGGCAGCATTATTG |
B1RR | Restored allele reverse primer | ACGGATCCACGCCTTAACCAACT |
G10RF | Restored allele forward primer | AGTGGGCCCCTTAGTATTCAACGA |
G10RR | Restored allele reverse primer | TGAGGGCCCGTATCATGACTTTG |
ADE1 | Forward primer | GAGACTATGCTGCTACTAAAGG |
Reverse primer | CAACACTTCGTCAACAAGAAC | |
ADE2 | Forward primer | CGATTCGGATCTACCAGTTATG |
Reverse primer | GGAGTTCTGTGTGCACTTAC | |
ADE4 | Forward primer | GTTGCCATGGCTAGAGAAG |
Reverse primer | TGGTGTCAGCTAAATCAATCC | |
ADE5,7 | Forward primer | CTCATATTACTGGTGGAGGATTAG |
Reverse primer | ATCTCTGGTACTTGCCATTG | |
ADE6 | Forward primer | GCAGCTGATATCCCTTCATTAG |
Reverse primer | TCCATACCAATGGCTTGAA | |
ADE8 | Forward primer | CTTTGGAGAAGGCAGGAATC |
Reverse primer | CTCCATCTTGACCAGCTTTC | |
ADE12 | Forward primer | GGTCCATTCCCAACAGAAC |
Reverse primer | ATCCAACCAACCACATCTTC | |
ADE13 | Forward primer | ACAAGAAGGTGGCGATAATG |
Reverse primer | GTTTGTTGAGGAGCTCTACC | |
ADE17 | Forward primer | AACAAGGTGCTGTTGATTTG |
Reverse primer | CTCCTAAGCCGATAACCATAC | |
MTD1 | Forward primer | TGTCCCATCCATTGGTAAAG |
Reverse primer | AAGAGGTCGCATCAGAAAC | |
SHM2 | Forward primer | CAAATTGATGGTGCTAGAGTTG |
Reverse primer | CTAACTCCACCTGGAACTAAAG | |
MIS11 (ADE3) | Forward primer | AATGTATGGTGCTGGTGAAG |
Reverse primer | GTCTTGGCGATACAGATTGG | |
NUP | Forward primer | GACCACCTCCATCAATGTC |
Reverse primer | TTGGAGTACCAGCAATAACC | |
TEF1 | Forward primer | TTCGTCAAATCCGGTGATG |
Reverse primer | CTGACAGCGAATCTACCTAATG |
Lowercase represents the nucleotides that anneal with the vector.
We introduced a functional allele of BAS1 into two bas1Δ strains, RAC108 and TF016Δ (20). For restored strain RAC111, we amplified a 3.2-kb fragment carrying the native BAS1 locus using primers B1RF and B1RR (Table 4). The fragment was inserted into the BamHI site of pGEM-HIS1, generating pGHBF. Plasmid pGHBF has a unique PshAI site located upstream of the BAS1 gene; RAC108 was transformed with PshAI-cleaved pGHBF, selecting for histidine prototrophy. Integration of BAS1::HIS1 into the bas1Δ::URA3 allele was confirmed by PCR amplification. To generate restored strain RAC255, we subcloned the 3.2-kb BamHI fragment from plasmid pGHBF into the SAT1 flipper-containing plasmid pSFS2 (57), generating plasmid pSFS2A-BAS1. TF016Δ was transformed with PshAI-cleaved pSFS2A-BAS1 and selecting for nourseothricin resistance (58). Integration was confirmed by PCR amplification using primers to BAS1 and within the SAT1 flipper cassette.
We introduced a functional allele of GRF10 into strain TF021Δ. GRF10 was amplified using primers G10RF and G10RR (Table 4), and was inserted into the PspOMI site of pGEM-HIS1, generating pGHPF. The 2.8-kb PspOMI fragment from plasmid pGHBF was subcloned into the PspOMI of pSFS2 (57), generating pSFS2A-GRF10. This plasmid was cleaved by BglII and transformed into TF021Δ, selecting for nourseothricin resistance, generating strain RAC256. Integration was confirmed by PCR amplification of genomic DNA using primers to GRF10 and within the SAT1 flipper cassette.
Media and growth conditions.
Strains were grown on yeast extract-peptone-dextrose (YPD) and synthetic dextrose (SD) medium (59) at 30°C. SD medium (2% dextrose, 6.7% yeast nitrogen base [YNB] plus ammonium sulfate) was supplemented with minimal supplements (0.5 mM uridine [Uri], 0.1 mM histidine, 0.1 mM arginine, and 0.15 mM adenine [Ade]). Synthetic complete (SC) medium was prepared by supplementing SD medium with CSM−Ade+Uri (Sunrise Science) (20). YPD medium containing 0.2 mM adenine was depleted for inorganic phosphate (YPD−Pi) as described previously (60). Hypha formation was monitored on the following solid 1.5% agar media: Spider medium (61), 10% fetal calf serum, and M-199 (Gibco-BRL) buffered with 155 mM HEPES (pH 7.5). All strains were maintained at 4°C on YPD plates and cultured monthly from frozen stocks.
Spot growth assay.
Strains were grown overnight in 5 ml YPD broth. The culture was diluted into sterile water to a starting optical density at 600 nm (OD600) of 0.1. The cultures were serially diluted 1:10 into sterile water; 3 μl of each dilution was spotted onto SC+Ade and SC–Ade plates. The plates were incubated at 30°C and photographed with an ImageQuant imager daily. Each strain was tested with at least three biological replicates.
Growth rate and doubling time determination.
Strains were grown overnight at 30°C in 5 ml YPD broth and diluted 1:50 dilution into SC+Ade and SC–Ade media. Two 200-μl samples were transferred from each diluted culture into separate wells of a 96-well plate that was placed at 30°C in a thermo-controlled GloMax plate reader. The OD600 of each well was measured every 30 min over 24 h, shaking the plate for 30 s prior to each OD600 reading. Samples were standardized to wells containing sterile medium. P values and standard deviation were calculated using the t test and standard deviation functions in Excel. Each strain test was performed with three biological replicates.
DNA microarray and data analysis.
Yeast strains DAY185 and RAC117 (grf10Δ null) were grown overnight in SD medium with minimal supplements and inoculated at a 1:50 dilution into 50 ml of fresh medium in triplicate. The cultures were grown until the mid-log phase (OD600 of ~0.5 to 1). The cells were quickly chilled in an ice-water bath and harvested by centrifugation, and RNA from three biological replicates was extracted using the RiboPure yeast kit, following the manufacturer’s instructions.
The gene profiling experiment was performed by ClinEuroDiag, Brussels, Belgium. Full genomic C. albicans DNA microarrays were developed and designed by the Galar Fungal Consortium and produced by ClinEuroDiag. Fluorescence-labeled cDNA was prepared from 1 μg of total RNA, using the Ambion amino allyl MessageAmp II aRNA postlabeling kit. After purification, both samples were combined and the volume was reduced. The labeled cDNA mix was resuspended in 60 µl hybridization buffer (ClinEuroDiag) and used for hybridization.
The microarrays were prehybridized at 42°C for at least 45 min. Afterwards slides were washed 5× with distilled water and spin-dried at 900 rpm at room temperature for 5 min. The labeled cDNA mixture was denatured for 2 min at 95°C prior to overnight hybridization (at least 16 h at 42°C) using the Advalytix hybridization station SB800 (Beckman Coulter, Inc.). The microarrays were washed for 5 min in 0.2× SSC–0.1% SDS with constant agitation at room temperature and rinsed for 5 min in 0.2× SSC at room temperature (1× SSC is 0.15 M NaCl plus 0.015 M sodium citrate). The microarrays were spin-dried at 900 rpm for 5 min. Afterwards the microarrays were scanned with the GenePix 4000B microarray scanner (Molecular Devices), and the signal intensities were analyzed using GenePix Pro 5.1 image acquisition and data analysis software (Molecular Devices).
Intensity-dependent normalization was performed by applying a locally weighted linear regression analysis (locally weighted scatterplot smoothing [LOWESS]). The data were calculated as a log of the signal intensities of the average of two identical spots (R1 and R2) for three biological replicates, and the P values were calculated. DNA microarray data were sorted based on the cutoff P value of <0.00001 and >2-fold change. Gene classification was based on the C. albicans GO term and performed using the GO Term Finder and Go Slim Mapper tools available at the Candida Genome Database website (candidagenome.org).
qRT-PCR analysis.
Cells were grown and harvested as previously described (62). Briefly, yeast strains were grown overnight in liquid SC medium, inoculated 1:50 into 25 ml of fresh SC+Uri+Ade medium, and grown at 30°C until reaching the mid-log phase (OD600 of ~0.5 to 1). The mid-log-phase culture was split in half, pelleted for 2 min at room temperature, washed twice with prewarmed SC+Uri+Ade or SC+Uri–Ade, and then resuspended in the same medium. After 15 min of incubation at 30°C, 5 ml of each sample was removed and quickly chilled in an ice-water bath, and cells were harvested by pelleting for 2 min at 4°C. The cell pellet was immediately frozen on dry ice and stored at −80°C. Three biological replicates were harvested for each sample.
RNA was extracted from the frozen cell pellets and converted to cDNA as previously described (13). The RT-qPCR was performed in duplicate using the SensiFAST SYBR No-ROX kit, as described previously (13). Gene TEF1 (EFT3) was included as a reference gene. All primers used in this study are listed in Table 4. The relative gene expression was calculated by the ΔCT method using a reference gene as described by Bio-Rad Laboratories. The Student’s t test and statistical significance were calculated by using Excel.
Virulence determination.
The determination of virulence of the bas1Δ strains RAC105, RAC108, and RAC111 was performed at the same time and in the same manner as for the grf10Δ strains that have been published (13). Briefly, C. albicans strains were grown in YPD broth at 30°C to stationary phase, washed twice with calcium- and magnesium-free phosphate-buffered saline (PBS), and resuspended in PBS at a cell density of 5 × 106 cells·ml−1 based on hemocytometer counts. Virulence in mice was assessed as described previously (38, 63). Groups of 10 male BALB/c mice (body weight, 20 to 22 g [Harlan]) were formed, and each mouse was injected through the lateral tail vein with a 200-µl inoculum containing 106 cells of wild-type control or mutant yeast. Mice were given food and water ad libitum. Survival of the mice was monitored twice daily, and moribund mice were euthanized by asphyxiation with carbon dioxide, as recommended by the American Veterinary Medical Association (64). Kaplan-Meier survival curves were created using SPSS 15.0 software; the survival curves were compared by the Mantel-Haenszel log-rank test as implemented in the package “survival” (65) for R (66).
Accession number(s).
Microarray data are available at the ArrayExpress database under accession no. E-MTAB-5798.
ACKNOWLEDGMENTS
This work was supported by NIH grants 1R03AI075226 and 1R15AI124160 and Georgetown University Pilot Project grant to R.J.R.; the Georgetown University Genomics and Epigenomics Shared Resource is partially supported by NIH/NCI grant P30-CA051008. The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
We thank Aaron Mitchell for providing strains and Shaun Brinsmade for assistance with qRT-PCR experiments.
REFERENCES
- 1.Underhill DM, Iliev ID. 2014. The mycobiota: interactions between commensal fungi and the host immune system. Nat Rev Immunol 14:405–416. doi: 10.1038/nri3684. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Odds FC. 1987. Candida infections: an overview. Crit Rev Microbiol 15:1–5. doi: 10.3109/10408418709104444. [DOI] [PubMed] [Google Scholar]
- 3.Lo HJ, Köhler JR, Didomenico B, Loebenberg D, Cacciapuoti A, Fink GR. 1997. Nonfilamentous C. albicans mutants are avirulent. Cell 90:939–949. doi: 10.1016/S0092-8674(00)80358-X. [DOI] [PubMed] [Google Scholar]
- 4.Braun BR, Head WS, Wang MX, Johnson AD. 2000. Identification and characterization of TUP1-regulated genes in Candida albicans. Genetics 156:31–44. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Saville SP, Lazzell AL, Monteagudo C, Lopez-Ribot JL. 2003. Engineered control of cell morphology in vivo reveals distinct roles for yeast and filamentous forms of Candida albicans during infection. Eukaryot Cell 2:1053–1060. doi: 10.1128/EC.2.5.1053-1060.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Carlisle PL, Banerjee M, Lazzell A, Monteagudo C, López-Ribot JL, Kadosh D. 2009. Expression levels of a filament-specific transcriptional regulator are sufficient to determine Candida albicans morphology and virulence. Proc Natl Acad Sci U S A 106:599–604. doi: 10.1073/pnas.0804061106. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Murad AM, d’Enfert C, Gaillardin C, Tournu H, Tekaia F, Talibi D, Marechal D, Marchais V, Cottin J, Brown AJ. 2001. Transcript profiling in Candida albicans reveals new cellular functions for the transcriptional repressors CaTup1, CaMig1 and CaNrg1. Mol Microbiol 42:981–993. doi: 10.1046/j.1365-2958.2001.02713.x. [DOI] [PubMed] [Google Scholar]
- 8.Doedt T, Krishnamurthy S, Bockmühl DP, Tebarth B, Stempel C, Russell CL, Brown AJP, Ernst JF. 2004. APSES proteins regulate morphogenesis and metabolism in Candida albicans. Mol Biol Cell 15:3167–3180. doi: 10.1091/10.1091/mbc.E03-11-0782. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Mulhern SM, Logue ME, Butler G. 2006. Candida albicans transcription factor Ace2 regulates metabolism and is required for filamentation in hypoxic conditions. Eukaryot Cell 5:2001–2013. doi: 10.1128/EC.00155-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Tripathi G, Wiltshire C, Macaskill S, Tournu H, Budge S, Brown AJP. 2002. Gcn4 co-ordinates morphogenetic and metabolic responses to amino acid starvation in Candida albicans. EMBO J 21:5448–5456. doi: 10.1093/emboj/cdf507. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Lan CY, Newport G, Murillo LA, Jones T, Scherer S, Davis RW, Agabian N. 2002. Metabolic specialization associated with phenotypic switching in Candida albicans. Proc Natl Acad Sci U S A 99:14907–14912. doi: 10.1073/pnas.232566499. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Brown AJP, Brown GD, Netea MG, Gow NAR. 2014. Metabolism impacts upon Candida immunogenicity and pathogenicity at multiple levels. Trends Microbiol 22:614–622. doi: 10.1016/j.tim.2014.07.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Ghosh AK, Wangsanut T, Fonzi WA, Rolfes RJ. 2015. The GRF10 homeobox gene regulates filamentous growth in the human fungal pathogen Candida albicans. FEMS Yeast Res 15:fov093. doi: 10.1093/femsyr/fov093. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Romanowski K, Zaborin A, Valuckaite V, Rolfes RJ, Babrowski T, Bethel C, Olivas A, Zaborina O, Alverdy JC. 2012. Candida albicans isolates from the gut of critically ill patients respond to phosphate limitation by expressing filaments and a lethal phenotype. PLoS One 7:e30119. doi: 10.1371/journal.pone.0030119. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Chauvel M, Nesseir A, Cabral V, Znaidi S, Goyard S, Bachellier-Bassi S, Firon A, Legrand M, Diogo D, Naulleau C, Rossignol T, D’Enfert C. 2012. A versatile overexpression strategy in the pathogenic yeast Candida albicans: identification of regulators of morphogenesis and fitness. PLoS One 7:e45912. doi: 10.1371/journal.pone.0045912. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Nobile CJ, Fox EP, Nett JE, Sorrells TR, Mitrovich QM, Hernday AD, Tuch BB, Andes DR, Johnson AD. 2012. A recently evolved transcriptional network controls biofilm development in Candida albicans. Cell 148:126–138. doi: 10.1016/j.cell.2011.10.048. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Daignan-Fornier B, Fink GR. 1992. Coregulation of purine and histidine biosynthesis by the transcriptional activators BAS1 and BAS2. Proc Natl Acad Sci U S A 89:6746–6750. doi: 10.1073/pnas.89.15.6746. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Rolfes RJ. 2006. Regulation of purine nucleotide biosynthesis: in yeast and beyond. Biochem Soc Trans 34:786–790. doi: 10.1042/BST0340786. [DOI] [PubMed] [Google Scholar]
- 19.Ljungdahl PO, Daignan-Fornier B. 2012. Regulation of amino acid, nucleotide, and phosphate metabolism in Saccharomyces cerevisiae. Genetics 190:885–929. doi: 10.1534/genetics.111.133306. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Homann OR, Dea J, Noble SM, Johnson AD. 2009. A phenotypic profile of the Candida albicans regulatory network. PLoS Genet 5:e1000783. doi: 10.1371/journal.pgen.1000783. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Donovan M, Schumuke JJ, Fonzi WA, Bonar SL, Gheesling-Mullis K, Jacob GS, Davisson VJ, Dotson SB. 2001. Virulence of a phosphoribosylaminoimidazole carboxylase-deficient Candida albicans strain in an immunosuppressed murine model of systemic candidiasis. Infect Immun 69:2542–2548. doi: 10.1128/IAI.69.4.2542-2548.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Jezewski S, von der Heide M, Poltermann S, Härtl A, Künkel W, Zipfel PF, Eck R. 2007. Role of the Vps34p-interacting protein Ade5,7p in hyphal growth and virulence of Candida albicans. Microbiology 153:2351–2362. doi: 10.1099/mic.0.2006/004028-0. [DOI] [PubMed] [Google Scholar]
- 23.Jiang L, Zhao J, Guo R, Li J, Yu L, Xu D. 2010. Functional characterization and virulence study of ADE8 and GUA1 genes involved in the de novo purine biosynthesis in Candida albicans. FEMS Yeast Res 10:199–208. doi: 10.1111/j.1567-1364.2009.00600.x. [DOI] [PubMed] [Google Scholar]
- 24.Inglis DO, Arnaud MB, Binkley J, Shah P, Skrzypek MS, Wymore F, Binkley G, Miyasato SR, Simison M, Sherlock G. 2012. The Candida genome database incorporates multiple Candida species: multispecies search and analysis tools with curated gene and protein information for Candida albicans and Candida glabrata. Nucleic Acids Res 40:D667–D674. doi: 10.1093/nar/gkr945. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Denis V, Daignan-Fornier B. 1998. Synthesis of glutamine, glycine and 10-formyl tetrahydrofolate is coregulated with purine biosynthesis in Saccharomyces cerevisiae. Mol Gen Genet 259:246–255. doi: 10.1007/s004380050810. [DOI] [PubMed] [Google Scholar]
- 26.Detke S. 1998. Cloning of the Candida albicans nucleoside transporter by complementation of nucleoside transport-deficient Saccharomyces. Yeast 14:1257–1265. doi:. [DOI] [PubMed] [Google Scholar]
- 27.Leach MD, Stead DA, Argo E, MacCallum DM, Brown AJP. 2011. Molecular and proteomic analyses highlight the importance of ubiquitination for the stress resistance, metabolic adaptation, morphogenetic regulation and virulence of Candida albicans. Mol Microbiol 79:1574–1593. doi: 10.1111/j.1365-2958.2011.07542.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Juchimiuk M, Orłowski J, Gawarecka K, Świeżewska E, Ernst JF, Palamarczyk G. 2014. Candida albicans cis-prenyltransferase Rer2 is required for protein glycosylation, cell wall integrity and hypha formation. Fungal Genet Biol 69:1–12. doi: 10.1016/j.fgb.2014.05.004. [DOI] [PubMed] [Google Scholar]
- 29.Chen C, Pande K, French SD, Tuch BB, Noble SM. 2011. An iron homeostasis regulatory circuit with reciprocal roles in Candida albicans commensalism and pathogenesis. Cell Host Microbe 10:118–135. doi: 10.1016/j.chom.2011.07.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Noble SM. 2013. Candida albicans specializations for iron homeostasis: from commensalism to virulence. Curr Opin Microbiol 16:708–715. doi: 10.1016/j.mib.2013.09.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Martchenko M, Levitin A, Hogues H, Nantel A, Whiteway M. 2007. Transcriptional rewiring of fungal galactose-metabolism circuitry. Curr Biol 17:1007–1013. doi: 10.1016/j.cub.2007.05.017. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Askew C, Sellam A, Epp E, Hogues H, Mullick A, Nantel A, Whiteway M. 2009. Transcriptional regulation of carbohydrate metabolism in the human pathogen Candida albicans. PLoS Pathog 5:e1000612. doi: 10.1371/journal.ppat.1000612. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Srikantha T, Soll DR. 1993. A white-specific gene in the white-opaque switching system of Candida albicans. Gene 131:53–60. doi: 10.1016/0378-1119(93)90668-S. [DOI] [PubMed] [Google Scholar]
- 34.Smith DA, Nicholls S, Morgan BA, Brown AJ, Quinn J. 2004. A conserved stress-activated protein kinase regulates a core stress response in the human pathogen Candida albicans. Mol Biol Cell 15:4179–4190. doi: 10.1091/mbc.E04-03-0181. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Enjalbert B, Smith DA, Cornell MJ, Alam I, Nicholls S, Brown AJ, Quinn J. 2006. Role of the Hog1 stress-activated protein kinase in the global transcriptional response to stress in the fungal pathogen Candida albicans. Mol Biol Cell 17:1018–1032. doi: 10.1091/mbc.E05-06-0501. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Hoyer LL, Payne TL, Hecht JE. 1998. Identification of Candida albicans ALS2 and ALS4 and localization of Als proteins to the fungal cell surface. J Bacteriol 180:5334–5343. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Hall RA, Bates S, Lenardon MD, MacCallum DM, Wagener J, Lowman DW, Kruppa MD, Williams DL, Odds FC, Brown AJ, Gow NA. 2013. The Mnn2 mannosyltransferase family modulates mannoprotein fibril length, immune recognition and virulence of Candida albicans. PLoS Pathog 9:e1003276. doi: 10.1371/journal.ppat.1003276. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Tsuchimori N, Sharkey LL, Fonzi WA, French SW, Edwards JE, Filler SG. 2000. Reduced virulence of HWP1-deficient mutants of Candida albicans and their interactions with host cells. Infect Immun 68:1997–2002. doi: 10.1128/IAI.68.4.1997-2002.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Noble SM, Johnson AD. 2005. Strains and strategies for large-scale gene deletion studies of the diploid human fungal pathogen Candida albicans. Eukaryot Cell 4:298–309. doi: 10.1128/EC.4.2.298-309.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Brand A, MacCallum DM, Brown AJ, Gow NA, Odds FC. 2004. Ectopic expression of URA3 can influence the virulence phenotypes and proteome of Candida albicans but can be overcome by targeted reintegration of URA3 at the RPS10 locus. Eukaryot Cell 3:900–909. doi: 10.1128/EC.3.4.900-909.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Mateos L, Jiménez A, Revuelta JL, Santos MA. 2006. Purine biosynthesis, riboflavin production, and trophic-phase span are controlled by a Myb-related transcription factor in the fungus Ashbya gossypii. Appl Environ Microbiol 72:5052–5060. doi: 10.1128/AEM.00424-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Hammond DJ, Gutteridge WE. 1984. Purine and pyrimidine metabolism in the Trypanosomatidae. Mol Biochem Parasitol 13:243–261. doi: 10.1016/0166-6851(84)90117-8. [DOI] [PubMed] [Google Scholar]
- 43.Heyworth PG, Gutteridge WE, Ginger CD. 1982. Purine metabolism in Trichomonas vaginalis. FEBS Lett 141:106–110. doi: 10.1016/0014-5793(82)80026-4. [DOI] [PubMed] [Google Scholar]
- 44.Reyes P, Rathod PK, Sanchez DJ, Mrema JE, Rieckmann KH, Heidrich HG. 1982. Enzymes of purine and pyrimidine metabolism from the human malaria parasite, Plasmodium falciparum. Mol Biochem Parasitol 5:275–290. doi: 10.1016/0166-6851(82)90035-4. [DOI] [PubMed] [Google Scholar]
- 45.Dean P, Hirt RP, Embley TM. 2016. Microsporidia: why make nucleotides if you can steal them? PLoS Pathog 12:e1005870. doi: 10.1371/journal.ppat.1005870. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Goddard MR, Greig D. 2015. Saccharomyces cerevisiae: a nomadic yeast with no niche? FEMS Yeast Res 15:fov009. doi: 10.1093/femsyr/fov009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Neiman AM, Pryciak P. 2011. Sporulation in the budding yeast Saccharomcyes cerevisiae. Genetics 189:737–765. doi: 10.1534/genetics.111.127126. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Traut TW. 1994. Physiological concentrations of purines and pyrimidines. Mol Cell Biochem 140:1–22. doi: 10.1007/BF00928361. [DOI] [PubMed] [Google Scholar]
- 49.Chitty JL, Fraser JA. 2017. Purine acquisition and synthesis by human fungal pathogens. Microorganisms 5:E33. doi: 10.3390/microorganisms5020033. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Wilson DW, Wilson HC. 1962. Studies in vitro of the digestion and absorption of purine ribonucleotides by the intestine. J Biol Chem 237:1643–1647. [PubMed] [Google Scholar]
- 51.Kirsch DR, Whitney RR. 1991. Pathogenicity of Candida albicans auxotrophic mutants in experimental infections. Infect Immun 59:3297–3300. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Samant S, Lee H, Ghassemi M, Chen J, Cook JL, Mankin AS, Neyfakh AA. 2008. Nucleotide biosynthesis is critical for growth of bacteria in human blood. PLoS Pathog 4:e37. doi: 10.1371/journal.ppat.0040037. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Valentino MD, Foulston L, Sadaka A, Kos VN, Villet RA, Santa Maria JJ, Lazinski DW, Camilli A, Walker S, Hooper DC, Gilmore MS. 2014. Genes contributing to Staphylococcus aureus fitness in abscess- and infection-related ecologies. mBio 5:e01729-14. doi: 10.1128/mBio.01729-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Davis D, Edwards JE, Mitchell AP, Ibrahim AS. 2000. Candida albicans RIM101 pH response pathway is required for host-pathogen interactions. Infect Immun 68:5953–5959. doi: 10.1128/IAI.68.10.5953-5959.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Fonzi WA, Irwin MY. 1993. Isogenic strain construction and gene mapping in Candida albicans. Genetics 134:717–728. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Wilson RB, Davis D, Mitchell AP. 1999. Rapid hypothesis testing with Candida albicans through gene disruption with short homology regions. J Bacteriol 181:1868–1874. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Reuss O, Vik A, Kolter R, Morschhäuser J. 2004. The SAT1 flipper, an optimized tool for gene disruption in Candida albicans. Gene 341:119–127. doi: 10.1016/j.gene.2004.06.021. [DOI] [PubMed] [Google Scholar]
- 58.Hernday AD, Noble SM, Mitrovich QM, Johnson AD. 2010. Genetics and molecular biology in Candida albicans. Methods Enzymol 470:737–758. doi: 10.1016/S0076-6879(10)70031-8. [DOI] [PubMed] [Google Scholar]
- 59.Sherman F. 1991. Getting started with yeast. Methods Enzymol 194:3–41. [DOI] [PubMed] [Google Scholar]
- 60.Rubin GM. 1974. Three forms of the 5.8-S ribosomal RNA species in Saccharomyces cerevisiae. Eur J Biochem 41:197–202. doi: 10.1111/j.1432-1033.1974.tb03260.x. [DOI] [PubMed] [Google Scholar]
- 61.Liu H, Köhler JR, Fink GR. 1994. Suppression of hyphal formation in Candida albicans by mutation of a STE12 homolog. Science 266:1723–1726. doi: 10.1126/science.7992058. [DOI] [PubMed] [Google Scholar]
- 62.Som I, Mitsch RN, Urbanowski JL, Rolfes RJ. 2005. DNA-bound Bas1 recruits Pho2 to activate ADE genes in Saccharomyces cerevisiae. Eukaryot Cell 4:1725–1735. doi: 10.1128/EC.4.10.1725-1735.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.Chauhan N, Ciudad T, Rodríguez-Alejandre A, Larriba G, Calderone R, Andaluz E. 2005. Virulence and karyotype analyses of rad52 mutants of Candida albicans: regeneration of a truncated chromosome of a reintegrant strain (rad52/RAD52) in the host. Infect Immun 73:8069–8078. doi: 10.1128/IAI.73.12.8069-8078.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64.AVMA 2001. 2000 Report of the AVMA panel on euthanasia. J Am Vet Med Assoc 218:669–696. [DOI] [PubMed] [Google Scholar]
- 65.Therneau TM, Grambsch PM. 2000. Modeling survival data: extending the Cox model. Springer, New York, NY. [Google Scholar]
- 66.R Development Core Team 2015. R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria: https://www.r-project.org/. [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.